Journal profile

Nuclear medicine communications

Publisher: Lippincott Williams & Wilkins
ISSN0143-3636 | 1473-5628 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
2.88
Citation rate 1.45 403 total citations
h5-index 19 h5 depth signal
Cited share 62.7% 180 of 287
Total citations 403 Citation footprint
Metric signal 1.32 External metric anchor
Self-citation 5.0% 20 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 336
United Kingdom 252
India 206
United States 177
Turkey 166

Citing Fields of Research

Biomedical Physics 347
Oncology 256
Radiation & Isotope-Based Techniques 190
Prostate Cancer 175
Endocrinology & Metabolism 169

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 11,261 Articles tracked across the journal lifetime
Indexed publication set 287 180 cited publications
Last 12 months 181 15.1 publications/month
Open access share 13.3% 24 OA publications in the last year
Leading citing country China 336 citing publications
Leading citing field Biomedical Physics 347 citing publications
Latest tracked publication 20 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v5n1, 1984-
PubMed
v5n1, 1984-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Prostate Cancer Endocrinology & Metabolism Biomedical Physics Oncology Lung Cancer Cardiology Liver & Colon Cancer

Issuing & Sponsoring Bodies

Contributor
British Nuclear Medicine Society

Broad Categories

Nuclear Medicine Endocrinology & Metabolism Lung Cancer Prostate Cancer Biomedical Physics Cardiology Musculoskeletal Disorders

MeSH Descriptors

Nuclear Medicine

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
Maged Elsewafy, Naomi Knox, Chamani Punchihewa et al.
Purpose: First, to assess the diagnostic value of fluorine-18-fluorodeoxyglucose PET-computed tomography ([ 18 F]-FDG PET-CT) compared with conventional MRI and/or CT. Second, to audit the clinical indications for referring patients with...
08
Fatma J. Al-Saeedi, Farah Y. Sohrabi, Dana A. Aryan et al.
Objective: To investigate the effects of glycyrrhizic acid on HepG2 cell viability and the cellular uptake, retention, and washout kinetics of technetium-99m methoxyisobutylisonitrile ( 99m Tc-MIBI), with particular emphasis on the poten...
09
Emine Bihter Eniseler, Ferhat Ekinci, Mustafa Şahbazlar et al.
Objective: To evaluate the prognostic value of the PET-derived SUVmax–lactate dehydrogenase–albumin–lymphocyte (SUV-LAL) index in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer treated with pertuzumab. ...
10
Gang Yan, Na Hu, Mengjuan Ran et al.
Objective: This study aimed to evaluate 18 F-fluorodeoxyglucose ( 18 F-FDG) PET/computed tomography (CT)-based deep learning for differentiating squamous cell carcinoma (SqCC) from adenocarcinoma (ADC) in non-small cell lung cancer (NSCL...

Bibliographical & Catalog Notes

Also issued online.

Vol. 4, no. 1 (1983)19920909 Notice not published Printed on acid-free paper